![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by Staff Writers El Segundo CA (SPX) Oct 15, 2015
NASA has selected Wyle as the successful bidder on the $1.4 billion Human Health and Performance Contract (HHPC). Under the terms of the contract, Wyle will support a broad range of human spaceflight activities, including fundamental and applied biomedical research; operational space medicine; occupational health and medicine at the Johnson Space Center and the White Sands Test Facility; management of clinical, biomedical, space food and environmental laboratories; design, fabrication, testing and operation of biomedical flight hardware; and payload and hardware integration with the International Space Station. HHPC is a single award, cost-plus-award-fee contract with indefinite-delivery, indefinite-quantity (IDIQ) task/delivery orders. The maximum value that can be ordered under the IDIQ portion of the base contract and option periods is $1.4 billion. The base period of performance is five years, starting October 1, 2015 through September 30, 2020. A three-year option and an additional two-year option are available. "Wyle is very pleased to be awarded NASA's Human Health and Performance Contract and have the opportunity to continue the important work performed under the predecessor Bioastronautics Contract," said Roger Wiederkehr, Wyle's CEO and president. "Advancing NASA's human spaceflight program is a critical undertaking, requiring the highest quality medical support, research and flight hardware development services. Wyle, by virtue of its 45-year history as a NASA partner, is uniquely qualified to deliver these high-value services." "We were very gratified to learn that Wyle's proposal was found to deliver the best value to NASA," said Dr. Vernon McDonald, president of Wyle's Science, Technology and Engineering Group. "Wyle's proposal received the highest mission suitability and past performance ratings and was evaluated as the lowest probable cost. These factors, combined with Wyle's highly qualified employees who strive for excellence in all they do, speak to a winning partnership in the years to come."
Related Links Wyle Space Medicine Technology and Systems
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |